Michigan approves ban on antidepressant tianeptine sodium

April 6, 2018

Michigan's governor has signed what's been described by state police as the nation's first statewide ban on the antidepressant tianeptine sodium.

The office of Republican Gov. Rick Snyder announced Thursday that he signed the measure to classify the as a Schedule II controlled substance, placing it in the same highly restrictive category that cocaine and fall under.

State police flagged the drug to a state lawmaker after a spate of gruesome overdoses in the Midland and Saginaw area in 2017.

Tianeptine sodium is an atypical antidepressant that is not approved by the Food and Drug Administration. It is marketed as a supplement or research chemical through unregulated vendors but is often abused in high doses to simulate opioid-like highs.

Explore further: FDA panel votes for tougher restrictions on hydrocodone

Related Stories

FDA panel votes for tougher restrictions on hydrocodone

January 26, 2013
(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor of moving hydrocodone ...

Strategies implemented to cut opioid ODs, deaths in maryland

June 15, 2017
(HealthDay)—Strategies are being implemented to reduce opioid overdoses and deaths in Maryland, according to a report published by the American Medical Association (AMA).

Opioid overdoses in ERs up 30 percent as crisis worsens

March 6, 2018
Emergency rooms saw a big jump in overdoses from opioids last year—the latest evidence the nation's drug crisis is getting worse.

New Mexico is 1st state to boost access to overdose antidote

April 6, 2017
New Mexico is the first state to require all local and state law enforcement agencies to provide officers with antidote kits as the state works to curb deaths from opioid and heroin overdoses.

Police try out new database for documenting opioid overdoses

August 14, 2017
Police in Massachusetts are testing a new database for documenting opioid overdoses they hope will help departments share information in real time and get people into treatment.

States ask insurers to prioritize non-opioid pain treatment

September 18, 2017
Attorneys general representing the majority of states are asking the insurance industry to encourage pain treatment through means other than prescriptions for opioid painkillers.

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

oliverlu70
not rated yet Apr 07, 2018
How many is a "spate"? Tianeptine is not even sold in English-speaking countries as far as I'm aware.

Perhaps Big Pharma was threatened by the existence of an SSRE? (selective serotonin reuptake enhancer--works the opposite of SSRIs, makes you question their hypothesis about low serotonin levels causing depression).

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.